Differential culture medium and culture method of tissue engineering skin

By using EGCG and other components in the differentiation medium of tissue-engineered skin and optimizing the culture method, the problem of epidermal stem cells being unable to differentiate in hydrogels was solved, achieving the effect of rapidly constructing complete skin tissue.

CN118979009APending Publication Date: 2024-11-19SUZHOU RUIHUA HOSPITAL +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411070188.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

In existing technologies, epidermal stem cells cannot differentiate normally into different layers of the epidermis in hydrogels, affecting the construction and function of tissue-engineered skin.

Method used

A differentiation culture medium for tissue-engineered skin, containing epigallocatechin gallate (EGCG) and other components, was used to induce epidermal stem cells to differentiate into various cell types of the epidermal layer. Optimized culture methods included cross-linking and gas-liquid culture, and a concentration of 1–2 μM EGCG was used to reduce cell damage.

Benefits of technology

It achieved rapid differentiation of epidermal stem cells, constructed a complete and functional skin tissue, reduced damage to other cells, and shortened the differentiation time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118979009A_ABST
    Figure CN118979009A_ABST
Patent Text Reader

Abstract

The invention provides a differentiation medium and a culture method of tissue engineering skin. The differential medium comprises epigallocatechin gallate (EGCG), and the culture cells comprise epidermal stem cells. The differential medium comprises 1-2 [mu] M EGCG, and the culture cells comprise epidermal stem cells and endothelial cells. The kit further comprises a basic culture medium, a bovine pituitary extract, a recombinant human insulin-like growth factor I, hydrocortisone, transferrin, an epidermal growth factor, serum, an endothelial cell growth factor, penicillin, streptomycin and a ROCK inhibitor, wherein the basic culture medium is KGM2 and ECM. The differentiation culture medium can induce epidermal stem cell differentiation of the epidermal layer, the epidermal stem cells gradually differentiate into keratinocytes of the epidermal layer, finally the epidermal outermost layer is achieved, a complete human epidermal structure is formed, and the differentiation culture medium has the structural characteristics and functions of normal skin and is beneficial to wound repair and healing.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biotechnology, and in particular to a differentiation culture medium and a culture method for tissue engineering skin. Background Art

[0002] Skin is the largest organ in the human body and also the most vulnerable organ. Large wounds are now often treated by transplanting skin flaps. With the development of tissue-engineered skin, 3D bioprinting has become an ideal means of constructing tissue-engineered skin in vitro. Ideal tissue-engineered skin should have the structural characteristics and functions of normal skin. The cell composition of the dermis and epidermis, the degree of epidermal differentiation, and the protein expression should be similar to those of normal human skin. The seed cells currently used for 3D printing of the epidermis are keratinocytes and stem cells. The keratinocytes isolated from human skin tissue are limited in their proliferation ability and number of expansions, which limits their application; immortalized keratinocyte cell lines (such as HaCaT cells) have strong proliferation ability and are easy to expand in vitro, but the properties and gene expression of these cells are different from those of normal skin epidermal cells. Epidermal stem cells in the basal layer of the epidermis of skin tissue are the progenitor cells of epidermal cells. Epidermal stem cells proliferate, migrate upward, and gradually differentiate into keratinocytes in the epidermis, eventually reaching the outermost layer of the epidermis, forming keratinocytes that fall off as dandruff. Therefore, epidermal stem cells were used as seed cells to construct the epidermis, and umbilical vein endothelial cells and fibroblasts were used to construct the dermis, so as to obtain vascularized 3D printed skin tissue with a structure similar to that of normal human skin tissue.

[0003] However, in the process of culturing tissue containing epidermal stem cells, endothelial cells and fibroblasts, we found that epidermal stem cells could not differentiate into the various layers of the epidermis normally in the hydrogel, and could not build a complete epidermis, which affected its function. At present, there is an urgent need to improve the culture method of skin tissue containing epidermal stem cells. Summary of the invention

[0004] The purpose of the present application is to provide a differentiation culture medium and a culture method for tissue engineered skin.

[0005] In order to achieve the purpose of this application, the present application provides a differentiation medium for tissue engineered skin, including epigallocatechin gallate (EGCG), and the cultured cells include epidermal stem cells. The differentiation medium of the present application includes EGCG and other ingredients, and the other ingredients can meet the normal growth of epidermal stem cells. The EGCG in the culture medium can induce epidermal stem cells to differentiate into various cells of the epidermis, including keratinocytes of the basal layer, spinous layer, granular layer, transparent layer and stratum corneum. However, different cells have different tolerance to EGCG. For example, umbilical vein endothelial cells are very sensitive to EGCG. Concentrations of 4μM and above will damage umbilical vein endothelial cells and cause cell death. For example, epidermal stem cells and fibroblasts can survive and metabolize normally at concentrations of EGCG below 50μM.

[0006] Regarding inducing epidermal stem cells to differentiate into various cells of the epidermis, conventional factors that induce human stem cell differentiation, such as epidermal growth factor and basic fibroblast growth factor, have been found in practice to have poor induction effects on epidermal stem cells in a three-dimensional environment and to be unable to form differentiated structures. For example, epidermal growth factor can induce tissue-engineered epidermal stem cells to grow into the dermis and form glandular structures, but it cannot induce them to differentiate into good epidermal cells.

[0007] Preferably, a differentiation culture medium for tissue engineered skin includes 1-2 μM epigallocatechin gallate, and the cultured cells include epidermal stem cells and endothelial cells.

[0008] Preferably, it also includes basal culture medium, bovine pituitary extract, recombinant human insulin-like growth factor I, hydrocortisone, transferrin, epidermal growth factor, serum, endothelial cell growth factor, penicillin, streptomycin and ROCK inhibitor, and the basal culture medium is KGM2 and ECM.

[0009] Preferably, the differentiation medium includes KGM2 and ECM in a volume ratio of (2-4):1, and the final concentrations of other components in the differentiation medium are: serum, 1%-5% of the volume of the basal medium;

[0010]

[0011] Preferably, the ROCK inhibitor is a Y-27632 inhibitor.

[0012] The present application also provides a method for culturing tissue engineered skin, using any of the above culture media to induce differentiation.

[0013] Preferably, the present application cross-links the epidermis and the dermis, and the cross-linked state is that the shape can still be maintained after being clamped, and the cross-linked printed tissue has good mechanical properties. After the cross-linked skin tissue is proliferated and cultured, the differentiation medium is used for gas-liquid culture, and the dosage is 1-1.5 ml of the differentiation medium for every 1 million epidermal stem cells.

[0014] Preferably, the differentiation culture time is 2 to 3 days.

[0015] Preferably, the proliferation culture uses a proliferation medium for immersion culture first and then gas-liquid culture, wherein the proliferation medium includes a basal culture medium, bovine pituitary extract, recombinant human insulin-like growth factor I, hydrocortisone, transferrin, epidermal growth factor, serum, endothelial cell growth factor, penicillin, streptomycin and ROCK inhibitor, and the basal culture medium is KGM2 and ECM.

[0016] Preferably, the proliferation medium comprises KGM2 and ECM in a volume ratio of (2-4):1, and the final concentrations of other components in the proliferation medium are: serum, 1%-5% of the volume of the basal medium;

[0017]

[0018] The present application also provides the use of any of the above-mentioned culture methods in constructing tissue-engineered skin.

[0019] In order to induce differentiation of tissues containing epidermal stem cells, EGCG, an active ingredient in tea polyphenols, was screened out through a large number of experiments. The inventors have found that within a certain range, the higher the concentration of EGCG added to the culture medium, the stronger the ability to induce differentiation, but the corresponding damage to epidermal stem cells, umbilical vein endothelial cells and fibroblasts is also greater. In order to minimize the damage of EGCG to epidermal stem cells, umbilical vein endothelial cells and fibroblasts, while at the same time inducing the differentiation of epidermal stem cells, a differentiation medium containing 1-2 μM EGCG was selected after comprehensive consideration after the experiment to induce differentiation of the epidermal layer of printed skin tissue, and the differentiation time is short.

[0020] According to the above technical solution, the present application has at least the following advantages and beneficial effects:

[0021] (1) The differentiation medium of the present application can induce the differentiation of epidermal stem cells in the epidermis. The epidermal stem cells gradually differentiate into keratinocytes in the epidermis and eventually reach the outermost layer of the epidermis, forming a complete human epidermal structure with the structural characteristics and functions of normal skin, which is conducive to wound repair and healing. If the tissue-engineered skin cannot differentiate into the epidermis or the tissue cells grow slowly, the wound will not be able to restore the structure and function of the original skin, affecting treatment and repair. In addition, the differentiation medium of the present application does not damage other cells in the dermis while inducing differentiation.

[0022] (2) Using the differentiation medium of the present application to induce differentiation can not only differentiate and culture a complete human epidermal structure, but also shorten the differentiation time.

[0023] (3) The culture method of the present application sequentially performs proliferation and differentiation culture on the cross-linked skin tissue, optimizes the tissue culture process, adjusts the culture methods at each stage, and obtains skin tissue that is closer to normal human skin tissue. In addition, the culture method of the present application is widely applicable to the construction and printing process of tissue engineering skin. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 This is a diagram of cell immunofluorescence detection in Example 1.

[0025] Figure 2 This is the cell immunofluorescence detection diagram of Example 2.

[0026] Figure 3 This is the cell immunofluorescence detection diagram of Example 3.

[0027] Figure 4 This is a diagram of cell immunofluorescence detection in Example 4.

[0028] Figure 5 This is the MTT test result diagram of Comparative Example 1.

[0029] Figure 6 This is the tissue immunofluorescence detection diagram of Comparative Example 2.

[0030] Figure 7 This is the cell immunofluorescence detection diagram of comparative example 3.

[0031] Figure 8 This is the staining diagram of the tissue section of Example 5.

[0032] Fig. 9 This is the tissue immunofluorescence detection diagram of Example 5. DETAILED DESCRIPTION

[0033] The method of the present application is described in detail below through specific examples, but the present application is not limited thereto, and any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application. The following examples are used to illustrate the present application, but are not used to limit the scope of the present application.

[0034] It should be understood that the experimental methods used in the following examples of this application are conventional methods unless otherwise specified.

[0035] A differentiation medium for tissue engineering skin, wherein the cultured cells include epidermal stem cells, and the differentiation medium includes KGM2 and ECM in a volume ratio of (2-4):1, which may be 2:1, 3:1 and 4:1 or any ratio therebetween; the final concentration of other components in the differentiation medium is: serum, which is 1% to 5% of the volume of the basal medium;

[0036] 25-70 μg / ml bovine pituitary extract, which can be 25 μg / ml, 30 μg / ml, 40 μg / ml, 50 μg / ml, 60 μg / ml, 70 μg / ml or any concentration therebetween;

[0037] 50-200 μg / ml endothelial cell growth factor, which can be 50 μg / ml, 100 μg / ml, 150 μg / ml, 200 μg / ml or any concentration therebetween;

[0038] 20-100 U / ml penicillin, which can be 20 U / ml, 30 U / ml, 40 U / ml, 50 U / ml, 60 U / ml, 70 U / ml, 80 U / ml, 90 U / ml, 100 U / ml or any concentration therebetween;

[0039] 0.02-0.1 mg / ml streptomycin, which may be 0.02 mg / ml, 0.05 mg / ml, 0.1 mg / ml or any concentration therebetween;

[0040] 0.006~0.02μg / ml recombinant human insulin-like growth factor Ⅰ;

[0041] 0.1-0.3 μg / ml hydrocortisone;

[0042] 3-8 μg / ml transferrin;

[0043] 0.1-0.4 ng / ml epidermal growth factor;

[0044] 5-20 μM ROCK inhibitor, which can be 5 μM, 10 μM, 15 μM, 20 μM or any concentration therebetween;

[0045] 1-2 μM EGCG, which can be 1 μM, 1.5 μM, 2 μM or any concentration therebetween. Too high a concentration of EGCG in the culture medium may cause damage to endothelial cells, etc., while too low a concentration may fail to achieve the effect of inducing complete differentiation.

[0046] The ROCK inhibitor can be Y-27632 or Y-33075, etc., preferably Y-27632 inhibitor. ROCK inhibitor can increase the survival and growth of stem cells.

[0047] The preparation process of differentiation medium includes the following steps:

[0048] 1. Mix KGM2 and ECM in proportion to obtain basal culture medium;

[0049] 2. Add the corresponding bovine pituitary extract, EGCG, recombinant human insulin-like growth factor I, hydrocortisone, transferrin, epidermal growth factor, serum, endothelial cell growth factor, penicillin, streptomycin and ROCK inhibitor to the basal culture medium in the previous step;

[0050] 3. After thorough mixing, filter and sterilize using a 0.22 μm filter membrane to obtain the above differentiation medium.

[0051] A method for culturing tissue engineered skin, as follows:

[0052] Epidermal stem cells were mixed into the epidermal hydrogel, and fibroblasts and umbilical vein endothelial cells were mixed into the dermal hydrogel. The epidermal layer and dermal layer were printed on the transwell in sequence using an extrusion 3D printer, and the 3D structure was cross-linked by irradiating with 405nm ultraviolet light for 60s and adding thrombin solution at 20℃ for 30min.

[0053] The cross-linked skin tissue is first immersed in a proliferation medium and then gas-liquid cultured. The proliferation medium includes KGM2 and ECM in a volume ratio of (2-4): 1, 25-70 μg / ml bovine pituitary extract, 1%-5% serum of the volume of the basic culture medium, 0.006-0.02 μg / ml recombinant human insulin-like growth factor I, 0.1-0.3 μg / ml hydrocortisone, 3-8 μg / ml transferrin, 0.1-0.4 ng / ml epidermal growth factor, 50-200 μg / ml endothelial cell growth factor, 20-100 U / ml penicillin, 0.02-0.1 mg / ml streptomycin solution, and 5-20 μM ROCK inhibitor. The medium is changed every two days.

[0054] The differentiation medium is used for gas-liquid culture, and the dosage is 1-1.5 ml of the differentiation medium for every 1 million epidermal stem cells. The differentiation culture time is 2-3 days. The conventional method cannot induce epidermal stem cell differentiation or the differentiation is slow, and the differentiation effect is not good. The culture method of the present application overcomes the above problems, can quickly induce differentiation, and obtain skin tissue with complete structure and complete functions.

[0055] Example 1

[0056] 1. Prepare proliferation medium. Mix KGM2 (Gibco EpiLife serum-free cell culture medium, catalog number: MEPI500CA) and ECM (Sciencell, catalog number: 1001) at a volume ratio of 4:1 as the basic culture medium, add 1% fetal bovine serum (Gibco, catalog number: A5669701), and the final concentrations of other components are: 20U / ml penicillin (source, catalog number:), 0.02mg / ml streptomycin (Gibco, catalog number: 15140148), 25μg / ml bovine pituitary extract (Corning, catalog number: 354123), 0 0.006 μg / ml recombinant human insulin-like growth factor I (Sigma-Aldrich, catalog number: 407251), 0.1 μg / ml hydrocortisone (Sigma-Aldrich, catalog number: H0396), 3 μg / ml bovine transferrin (Gibco, catalog number: 11107067), 0.1 ng / ml human epidermal growth factor (Sigma-Aldrich, catalog number: E5036), 50 μg / ml endothelial growth factor (Corning, catalog number: 354006) and 5 μM Y-27632 (Sigma-Aldrich, catalog number: Y0503). After fully mixing, the mixture was sterilized by filtration using a 0.22 μm filter membrane to obtain a proliferation medium.

[0057] 2. Prepare differentiation medium. Mix KGM2 and ECM in a volume ratio of 4:1 as the basic medium, add 1% fetal bovine serum, and other components and final concentrations are as follows: 25μg / ml bovine pituitary extract, 1μM EGCG (Stande, catalog number: 989-51-5), 20U / ml penicillin, 0.02mg / ml streptomycin, 0.006μg / ml recombinant human insulin-like growth factor I, 0.1μg / ml hydrocortisone, 3μg / ml bovine transferrin, 0.1ng / ml human epidermal growth factor, 50μg / ml endothelial cell growth factor and 5μM Y-27632. After fully mixing, filter and sterilize with a 0.22μm filter membrane to obtain differentiation medium.

[0058] 3. Cell extraction and separation.

[0059] (1) Isolation and culture of epidermal stem cells:

[0060] Day 1: Digestion of human skin tissue (from the First Affiliated Hospital of Soochow University and Ruihua Hospital Affiliated to Soochow University): Under sterile conditions, subcutaneous fat and part of the dermis were removed, and then washed three times with double-antibody PBS solution. The skin tissue was then cut into tissue blocks of about 0.5×0.5 cm, and 0.25% neutral protease II solution was added, so that the liquid level just reached the junction of the dermis and epidermis, and the epidermis was exposed above the liquid surface, and digested at 4°C for 13 hours.

[0061] The next day: Add 2 ml of type IV collagen to a 6 cm culture dish and coat it in a cell culture incubator for 1 hour. Under sterile conditions, use tweezers to separate the epidermis from the dermis. Chop the epidermis into foam, add 2 ml of 0.25% trypsin solution to blow away the epidermal foam, and move it to a cell culture incubator for digestion for 15 minutes. Add fetal bovine serum at a ratio of 10:1 to 0.25% trypsin, and continue to blow until it is completely blown away. After filtering the cell suspension through a 70 μm filter to remove skin fragments, centrifuge it at 1500 rpm in a horizontal centrifuge for 3 minutes, carefully remove the supernatant with a negative pressure pump, and resuspend the precipitate with complete KGM2 culture medium. Recover type IV collagen in the 6 cm culture dish and wash it once with PBS. After counting the cells, press 1×10 5 cells / cm 2 , the cells were inoculated in a cleaned 6cm culture dish, placed in a cell culture incubator for 10 minutes, the culture medium was removed, washed once with PBS, and then replaced with new complete KGM2 culture medium for continued culture. The remaining cells in the culture dish were epidermal stem cells, and 10μM Y-27632 was added to the culture medium to inhibit epidermal stem cell differentiation. After that, the complete KGM2 culture medium was replaced every 48 hours, and after the cells expanded to more than 80% confluence, they were passaged at a ratio of 1:2 (the culture dish also needed to be pre-coated with type IV collagen in advance). P1 to P2 generations of human epidermal stem cells were used in subsequent printed tissues, and they were cultured in complete KGM2 culture medium without Y-27632 before the experiment.

[0062] (2) Isolation and culture of fibroblasts:

[0063] The dermis of the human skin tissue was minced, and 2 mg / ml type II collagenase solution was added (volume of collagenase solution: volume of dermis = 4:1). The mixture was collected in a 15 ml centrifuge tube and shaken at 150 rpm at 37 °C in the dark for 3 h. Complete DMEM medium twice the volume of the digestion solution was added to terminate the collagenase digestion, and the undigested tissue was filtered out using a 70 μm filter. The filtrate was collected in a 15 ml centrifuge tube and centrifuged at 1500 rpm for 3 min in a horizontal centrifuge. The supernatant was removed, and the cells were resuspended in complete DMEM medium, inoculated in a culture dish, and transferred to a 37 °C, 5% CO2 incubator for culture. The medium was changed every 3 days. Cells from the 1st to 9th generations were used as seed cells for 3D printing.

[0064] (3) Isolation and culture of umbilical vein endothelial cells:

[0065] Human umbilical cord tissue (from the First Affiliated Hospital of Soochow University and Wuzhong District People's Hospital of Suzhou) was obtained, and the surface was sprayed with 75% ethanol for disinfection 3 times, and washed with PBS containing 1% penicillin-streptomycin 3 times, each time for 5 minutes. The edema tissue at both ends of the umbilical cord was cut off, and two umbilical arteries and one umbilical vein were separated, and the umbilical arteries at both ends were ligated. The front needle part of the intravenous indwelling needle was cut off, and an appropriate amount of soft tube was retained, inserted into the umbilical vein and fixed with sutures around the umbilical cord; an appropriate amount of PBS mixed with heparin was used to flush and remove blood clots in the umbilical vein. The lower umbilical vein was clamped with a hemostatic forceps, and an appropriate amount of type II collagenase was injected into the umbilical vein to fully fill the umbilical vein, and the indwelling needle needle was sealed. The armpit was placed in a 15cm culture dish and digested at room temperature for 30 minutes. The lower end hemostatic forceps were loosened to allow the digestion fluid to flow into a 50ml centrifuge tube; a complete DMEM medium twice the volume of the digestion fluid was injected into the umbilical vein to flush the umbilical vein and terminate the digestion, and the flushing fluid was collected into a 50ml centrifuge tube. The collected cell suspension was filtered through a 70 μm filter, centrifuged (1500 rpm, 3 min), the supernatant was removed, the cells were resuspended in ECM complete medium, inoculated into a culture dish, and the culture dish was transferred to a 37°C, 5% CO2 incubator for culture, and the medium was changed every 2 days. The 1st to 9th generation cells were used as seed cells for 3D printing.

[0066] 4. Culture of tissue-engineered skin: epidermal stem cells (5×10 6 / ml) were mixed in the epidermal hydrogel and fibroblasts (1×10 6 / ml) and umbilical vein endothelial cells (4×10 6 / ml) was mixed in the dermis hydrogel. The epidermis and dermis were printed on the transwell in sequence by an extrusion 3D printer, and the 3D structure was cross-linked by 405nm ultraviolet light irradiation for 60s and thrombin solution added at 20℃ for 30min.

[0067] The cross-linked skin tissue was cultured in 5 ml proliferation medium, first by immersion culture for 4 days, then by air-liquid culture for 6 days, with the medium changed every two days.

[0068] The cells were then cultured in 7.5 ml of the differentiation medium. The cells were cultured and observed, and the differentiation marker K1 was detected by immunofluorescence. Figure 1 As shown, epidermal stem cells are partially differentiated on the first day and fully differentiated on the third day.

[0069] Example 2

[0070] 1. Prepare proliferation medium. Evenly mix KGM2 (model) and ECM (model) at a volume ratio of 3:1 as the basic medium, add 5% fetal bovine serum, and other components and final concentrations are as follows: 70μg / ml bovine pituitary extract, 100U / ml penicillin, 0.1mg / ml streptomycin, 0.02μg / ml recombinant human insulin-like growth factor I, 0.3μg / ml hydrocortisone, 8μg / ml bovine transferrin, 0.4ng / ml human epidermal growth factor, 200μg / ml endothelial cell growth factor and 20μM Y-27632. After fully mixing, filter and sterilize with a 0.22μm filter membrane to obtain proliferation medium.

[0071] 2. Prepare differentiation medium. Mix KGM2 and ECM in a volume ratio of 3:1 as the basic medium, add 5% fetal bovine serum, and other components and final concentrations are as follows: 70μg / ml bovine pituitary extract, 2μM EGCG, 100U / ml penicillin, 0.1mg / ml streptomycin, 0.02μg / ml recombinant human insulin-like growth factor I, 0.3μg / ml hydrocortisone, 8μg / ml bovine transferrin, 0.4ng / ml human epidermal growth factor, 200μg / ml endothelial cell growth factor and 20μM Y-27632. After fully mixing, filter and sterilize with a 0.22μm filter membrane to obtain differentiation medium.

[0072] 3. Cell extraction and separation are the same as in Example 1.

[0073] 4. Culture of tissue-engineered skin: epidermal stem cells (5×10 6 / ml) were mixed in the epidermal hydrogel and fibroblasts (1×10 6 / ml) and umbilical vein endothelial cells (4×10 6 / ml) was mixed in the dermis hydrogel. The epidermis and dermis were printed on the transwell in sequence by an extrusion 3D printer, and the 3D structure was cross-linked by 405nm ultraviolet light irradiation for 60s and thrombin solution added at 20℃ for 30min.

[0074] The cross-linked skin tissue was cultured in 5 ml proliferation medium, first by immersion culture for 4 days, then by air-liquid culture for 3 days, with the medium changed every two days.

[0075] After 3 days of air-liquid culture, 5 ml of the differentiation medium was used for air-liquid culture. Culture and observation were performed, and the differentiation marker K1 was detected by immunofluorescence. Figure 2 As shown, epidermal stem cells are partially differentiated on the first day and fully differentiated on the third day.

[0076] Example 3

[0077] The proliferation culture medium uses an existing proliferation culture medium, DMEM / F12 culture medium is used as the basic culture medium, 1% fetal bovine serum is added, and the remaining components and final concentrations are as follows: 25μg / ml bovine pituitary extract, 20U / ml penicillin, 0.02mg / ml streptomycin, 0.006μg / ml insulin, 0.1μg / ml hydrocortisone, 3μg / ml bovine transferrin, 0.1ng / ml human epidermal growth factor, 50μg / ml endothelial growth factor and 4ng / ml basic fibroblast growth factor.

[0078] The differentiation medium was the same as in Example 2. The cell extraction and separation was the same as in Example 2.

[0079] The tissue-engineered skin was cultured as follows: epidermal stem cells (5×10 6 / ml) were mixed in the epidermal hydrogel and fibroblasts (1×10 6 / ml) and umbilical vein endothelial cells (4×10 6 / ml) was mixed in the dermis hydrogel. The epidermis and dermis were printed on the transwell in sequence by an extrusion 3D printer, and the 3D structure was cross-linked by 405nm ultraviolet light irradiation for 60s and thrombin solution added at 20℃ for 30min.

[0080] The cross-linked skin tissue was cultured with 5 ml of the proliferation medium of this embodiment, immersed for 4 days, and then cultured in air and liquid for 12 days, with the medium changed every two days. The proliferation medium of this embodiment has a promoting effect on the proliferation of the above cells, but the splitting and proliferation effect is not as good as that of the preferred proliferation medium of this application, and the proliferation rate is slower.

[0081] The cells were then cultured in 7.5 ml of the differentiation medium. The cells were cultured and observed, and the differentiation marker K1 was detected by immunofluorescence. Figure 3 As shown, epidermal stem cells are partially differentiated on the first day and fully differentiated on the third day.

[0082] Example 4

[0083] A differentiation medium for tissue engineering skin, comprising KGM2 and ECM, a volume ratio of KGM2 to ECM of 4:1, as well as 10 μM Y-27632 and different concentrations of EGCG, the cultured cells are epidermal stem cells. Epidermal stem cells were induced to differentiate with 1, 2 and 4 μM EGCG for 0, 1, 2 and 3 days, respectively, RNA was extracted, and the expression of differentiation markers keratin 1 (K1), keratin 10 (K10), involucrin (IVL), loricrin (LOR) and filaggrin (FLG) at the RNA level was detected by RT-qPCR. Figure 4As shown, within a reasonable concentration range, as the EGCG concentration increases, the expression of differentiation markers of epidermal stem cells is relatively more, and the ability to induce differentiation is stronger.

[0084] Comparative Example 1

[0085] The differentiation medium is the same as in Example 4, except that the cultured cells are umbilical vein endothelial cells. The cells are cultured and observed, and the MTT assay is used to detect that Figure 5 As shown, when the concentration of EGCG is 1 μM or 2 μM, the umbilical vein endothelial cells will not be damaged. When the concentration of EGCG is 4 μM, the umbilical vein endothelial cells are damaged after 2 days of culture, eventually leading to cell death.

[0086] Comparative Example 2

[0087] The proliferation culture medium and cell extraction and separation were the same as in Example 1.

[0088] The differentiation medium was the same as the proliferation medium, but the concentration of human epidermal growth factor was 20 ng / ml.

[0089] Cell extraction and separation and tissue engineering skin culture are the same as in Example 1. The results show that the proliferation medium has a promoting effect on the proliferation of the above cells, but the epidermal stem cells cannot differentiate into the epidermis. Although the differentiation medium of this comparative example can induce epidermal stem cells to differentiate in a two-dimensional environment, in a three-dimensional environment, the differentiation medium cannot differentiate into various cells of the epidermis, nor can it induce the epidermal stem cells to change their morphology to a differentiated state (the differentiation state refers to the inability to maintain the cobblestone or paving stone state of the epidermal stem cells, but to transform into an irregular state such as a flat elongated state). Figure 6 As shown, tissue immunofluorescence detection revealed that differentiation medium could not induce epidermal stem cells to express differentiation markers K1 and involucrin (IVL).

[0090] Comparative Example 3

[0091] The proliferation medium, differentiation medium and cell extraction and separation were the same as in Example 1, except that the EGCG in the differentiation medium was 4 μM. The tissue-engineered skin was cultured and observed as in Example 1, and the differentiation marker K1 was detected by immunofluorescence. Figure 7 As shown in Figure 1, epidermal stem cells partially differentiate on the first day and fully differentiate on the third day. Figure 5 The umbilical vein endothelial cell proliferation experiment showed that 4μM EGCG had a toxic effect on umbilical vein endothelial cells and was not conducive to the proliferation of umbilical vein endothelial cells.

[0092] Example 5 Tissue Engineering Skin Repair of Skin Wounds

[0093] 6-week-old BALB / c-nu nude mice were selected and anesthetized with 25% sodium pentobarbital (35 mg / kg). The skin was disinfected with iodine, and a full-thickness skin defect with a diameter of 8 mm was prepared on the back of the mouse using a punch biopsy device. An observation device was placed at the wound, and the 3D printed skin tissue prepared in Example 2 was implanted on the wound surface.

[0094] After 14 days of implantation, the graft was kept moist, and the graft was removed and frozen and cut. The thickness and gross structure of the dermis and epidermis were observed by H&E staining. The epidermal stem cell differentiation marker K1 was used to observe epidermal differentiation. The vascular marker CD31 was used to observe blood vessel formation. FITC-dextran was injected into the rat tail to observe the formation of blood vessels in the graft dermis and the blood circulation of nude mice. After 10 days of culture, the 3D printed tissue skin was frozen and sliced, and the slices were stained with H&E. Figure 8 As shown in the results, the thickness of the epidermis of the tissue induced by differentiation with 2 μM EGCG for 3 days was thicker than that of the tissue without differentiation, but both were close to the thickness of the epidermis of normal human skin. Fig. 9 As shown, after 3 days of differentiation induced by 2μM ECG, the differentiation marker molecule K1 was observed by immunofluorescence, the epidermal stem cells were successfully differentiated, the epidermal structure was intact, and immunofluorescence observed that dermal blood vessels were formed and connected with the blood vessels of nude mice, achieving blood circulation function.

[0095] Although the present application has been described in detail above with general descriptions and specific implementation methods, it is obvious to those skilled in the art that some modifications or improvements can be made to the present application. Any equivalent structure or equivalent process transformation made by using the contents of the present application specification and drawings, or directly or indirectly applied in other related technical fields, are also included in the patent protection scope of the present application.

Claims

1. A differentiation medium for tissue engineering skin, characterized in that: The differentiation medium includes epigallocatechin gallate, and the cultured cells include epidermal stem cells.

2. A differentiation medium for tissue engineering skin according to claim 1, characterized in that: The differentiation medium comprises 1-2 μM epigallocatechin gallate, and the cultured cells comprise epidermal stem cells and endothelial cells.

3. A differentiation medium for tissue engineering skin according to claim 2, characterized in that: It also includes basic culture medium, bovine pituitary extract, recombinant human insulin-like growth factor I, hydrocortisone, transferrin, epidermal growth factor, serum, endothelial cell growth factor, penicillin, streptomycin and ROCK inhibitor, and the basic culture medium is KGM2 and ECM.

4. A differentiation medium for tissue engineering skin according to claim 3, characterized in that: The volume ratio of KGM2 and ECM is (2-4):1; the final concentration of other components in the differentiation medium is: serum, which is 1%-5% of the volume of the basic medium; 5. A differentiation medium for tissue engineering skin according to claim 3 or 4, characterized in that: The ROCK inhibitor is a Y-27632 inhibitor.

6. A method for culturing tissue engineered skin, characterized in that: The differentiation is induced using the culture medium according to any one of claims 1 to 5.

7. The method for culturing tissue engineered skin according to claim 6, characterized in that: The epidermis and dermis are cross-linked, and after the cross-linked skin tissue is proliferated and cultured, the differentiation medium is used for gas-liquid culture, and the dosage is 1-1.5 ml of the differentiation medium for every 1 million epidermal stem cells.

8. The method for culturing tissue engineered skin according to claim 7, characterized in that: The differentiation culture time is 2 to 3 days.

9. The method for culturing tissue engineered skin according to claim 7, characterized in that: Proliferation culture uses a proliferation medium for immersion culture first and then gas-liquid culture, the proliferation medium includes a basal culture medium, bovine pituitary extract, recombinant human insulin-like growth factor I, hydrocortisone, transferrin, epidermal growth factor, serum, endothelial cell growth factor, penicillin, streptomycin and ROCK inhibitor, and the basal culture medium is KGM2 and ECM; Preferably, the proliferation medium includes KGM2 and ECM in a volume ratio of (2-4):1; the final concentrations of other components in the proliferation medium are: serum, 1%-5% of the volume of the basal medium; 10. Use of the culture method according to any one of claims 6 to 9 in constructing tissue engineering skin.